Page 868 - Small Animal Clinical Nutrition 5th Edition
P. 868

Canine Struvite Urolithiasis  899




        VetBooks.ir  Table 43-5. Key nutritional factors in selected commercial veterinary therapeutic foods used for dissolution of struvite uroliths in dogs
                    compared to recommended levels.*
                    Dry foods
                    Recommended levels                       Protein (%)  Phosphorus (%)  Magnesium (%)  Urinary pH**
                                                                 ≤8
                                                                                                          5.9-6.1
                                                                                            <0.02
                                                                              ≤0.1
                    Royal Canin Veterinary Diet Control Formula  23.9         0.84          0.130         6.0-6.3
                    Royal Canin Veterinary Diet Urinary SO 14   17.0          0.63          0.066         5.5-6.0
                    Moist foods                              Protein (%)  Phosphorus (%)  Magnesium (%)  Urinary pH**
                    Recommended levels                           ≤8           ≤0.1          <0.02         5.9-6.1
                    Hill’s Prescription Diet s/d Canine          7.9          0.10          0.024          5.935
                    Royal Canin Veterinary Diet Control Formula  22.8         0.66          0.078         6.0-6.3
                    Royal Canin Veterinary Diet Urinary SO      18.5          0.86          0.059         5.5-6.0
                    *Manufacturers’ published values; nutrients expressed on a dry matter basis; moist foods are best.
                    **Protocols for measuring urinary pH may vary.


                    Table 43-6. Characteristic clinical findings before and after initiation of dietary and medical therapy, or dietary therapy alone, to dissolve
                    struvite uroliths in nonazotemic dogs.*

                    Factors                          Pre-therapy          During therapy       After successful therapy**
                    Polyuria                             ±                   1+ to 3+                 Negative
                    Pollakiuria                        1+ to 4+        Transient ↑; subsequent ↓      Negative
                    Gross hematuria                    0 to 4+            ↓ by 5 to 10 days           Negative
                    Abnormal urine odor                0 to 4+            ↓ by 5 to 10 days           Negative
                    Small uroliths voided                ±               Common in females            Negative
                    Urine specific gravity             Variable            1.004 to 1.014             Normal
                    Urinary pH                           ≥7            Decreased (usually acidic)     Variable
                    Urine protein                      1+ to 4+         Decreased to absent           Negative
                    Urine RBC                          1+ to 4+         Decreased to absent           Negative
                    Urine WBC                          1+ to 4+         Decreased to absent           Negative
                    Struvite crystals                  0 to 4+             Usually absent             Variable
                    Other crystals                     Variable             May persist              May persist
                    Bacteriuria                        0 to 4+          Decreased to absent           Negative
                    Quantitative bacterial urine culture   0 to 4+      Decreased to absent           Negative
                    Serum urea nitrogen               >15 mg/dl             <10 mg/dl             Dependent on food
                    Serum creatinine                   Normal                Normal                   Normal
                    Serum alkaline phosphatase         Normal             ↑ by 2 to 5 times           Normal
                    Serum albumin                      Normal             ↓ by 0.5 to 1 g/dl          Normal
                    Serum phosphorus                   Normal             Slight decrease             Normal
                    Urolith size (radiographic)      Small to large     Progressive decrease          Negative
                    Hemogram                           Normal                Normal                   Normal

                    *For dogs with urinary tract infection, therapy consists of a litholytic food and antimicrobial agents. For dogs without urinary tract
                    infection, therapy consists of a litholytic food.
                    **All forms of therapy withdrawn.



                  body condition, serum albumin concentration and packed  AZOTEMIC PRIMARY RENAL FAILURE
                  cell volume for evidence of protein-calorie malnutrition  Complete obstruction of urine outflow caused by uroliths in
                  should be considered. Adjustments in dietary management  patients with a concomitant UTI should be regarded as an
                  should be made if marked reductions in these variables are  emergency. In this situation, a combination of obstruction and
                  observed. The urocystoliths may be removed by voiding uro-  pyelonephritis caused by a rapid spread of infection throughout
                  hydropropulsion (Figure 38-5 and Table 38-7) or lithotripsy,  the kidneys is likely to induce acute renal failure and then sep-
                  if their size has been reduced enough to permit their passage  ticemia. Dietary dissolution of struvite uroliths located in the
                  pass through a distended urethra (Lulich et al, 1993).  upper urinary tract should not be considered until adequate
                                                                      urine flow has been restored, and life-threatening deficits and
                    ABNORMAL FLUID RETENTION                          excesses in fluid, electrolyte, acid-base and endocrine balance
                    Properly formulated struvite litholytic foods are restricted in  have been corrected.
                  protein and supplemented with sodium chloride. Both could  Nonobstructing struvite nephroliths have been dissolved in
                  affect fluid balance. Therefore, the food should not be rou-  patients with nonazotemic renal failure caused by ascending
                  tinely fed to patients with comorbid diseases associated with  pyelonephritis (Osborne et al, 1985, 1986). But, protein-re-
                  positive fluid balance (e.g., heart failure, nephrotic syndrome)  stricted litholytic foods should be used with caution in patients
                  or hypertension.                                    with azotemic primary renal failure. Such foods may induce
   863   864   865   866   867   868   869   870   871   872   873